Original Article | Published:

Chronic Administration of the Methylxanthine Propentofylline Impairs Reinstatement to Cocaine by a GLT-1-Dependent Mechanism

Neuropsychopharmacology volume 39, pages 499506 (2014) | Download Citation

Subjects

Abstract

In recent years, interactions between neurons and glia have been evaluated as mediators of neuropsychiatric diseases, including drug addiction. In particular, compounds that increase expression of the astroglial glutamate transporter GLT-1 (N-acetylcysteine and ceftriaxone) can decrease measures of drug seeking. However, it is unknown whether the compounds that influence broad measures of glial physiology can influence behavioral measures of drug relapse, nor is it clear whether the upregulated GLT-1 is functionally important for suppressing of drug seeking. To address these questions, we sought to determine whether the glial modulator and neuroprotective agent propentofylline (PPF) modifies drug seeking in rats using a reinstatement model of cocaine relapse. We found that 7 days of chronic (but not acute) administration of PPF significantly decreased both cue- and cocaine-induced reinstatement of cocaine seeking. We next determined whether the effect of systemic PPF on reinstatement depended upon its ability to restore expression of GLT-1 in the nucleus accumbens. PPF restored the cocaine-induced decrease in GLT-1 in the accumbens core; then, using an antisense strategy against glutamate transporter GLT-1, we found that restored transporter expression was necessary for PPF to inhibit cue-primed cocaine seeking. These findings indicate that modulating glial physiology with atypical xanthine derivatives like PPF is a potential avenue for developing new medications for cocaine abuse, and support the hypothesis that neuron–glial interactions contribute to mechanisms of psychostimulant addiction, particularly via expression and function of astroglial glutamate transporters.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. , , (2013). Microglia: scapegoat, saboteur, or something else? Science 339: 156–161.

  2. (2008). The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 60: 430–440.

  3. , , (1993). Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area. J Neurochem 61: 1766–1773.

  4. , , , , (2005). Glutamate uptake is attenuated in spinal deep dorsal and ventral horn in the rat spinal nerve ligation model. Brain Res 1041: 38–47.

  5. , , , (1998). Effects of propentofylline on adenosine receptor activity in Chinese hamster ovary cell lines transfected with human A1, A2A, or A2B receptors and a luciferase reporter gene. Can J Physiol Pharmacol 76: 1132–1138.

  6. , (2003). Forebrain astroglial plasticity is induced following withdrawal from repeated cocaine administration. Eur J Neurosci 17: 1273–1278.

  7. , , , , (2012). mGlu5 and adenosine A2A receptor interactions regulate the conditioned effects of cocaine. Int J Neuropsychopharmacol 15: 995–1001.

  8. , , , (2006). Altered discharges of spinal wide dynamic range neurons and down-regulation of glutamate transporter expression in rats with paclitaxel-induced hyperalgesia. Neuroscience 138: 329–338.

  9. , , , (2002). Similar perisynaptic glial localization for the Na+,K+-ATPase alpha 2 subunit and the glutamate transporters GLAST and GLT-1 in the rat somatosensory cortex. Cereb Cortex 12: 515–525.

  10. , , , , , et al (2005). Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence. Addiction 100(Suppl 1): 12–22.

  11. , , (2012). Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances. Expert Opin Investig Drugs 21: 169–178.

  12. , (2009). Chronic obstructive pulmonary disease in the elderly: an update on pharmacological management. Drugs Aging 26: 447–456.

  13. , (2008). The neurocircuitry of addiction: an overview. Br J Pharmacol 154: 261–274.

  14. , , (2012). Differential effects of cocaine access and withdrawal on glutamate type 1 transporter expression in rat nucleus accumbens core and shell. Neuroscience 210: 333–339.

  15. , , (2003). Propentofylline for dementia. Cochrane Database Syst Rev CD002853.

  16. , , , , (2011). Alcohol-seeking behavior is associated with increased glutamate transmission in basolateral amygdala and nucleus accumbens as measured by glutamate-oxidase-coated biosensors. Addict Biol 16: 215–228.

  17. , , , , , et al (2013). Reinstatement of nicotine seeking is mediated by glutamatergic plasticity. Proc Natl Acad Sci USA 110: 9124–9129.

  18. (2009). The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10: 561–572.

  19. , (2003). Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl) 168: 44–56.

  20. , , (1997). Clinical trials in dementia with propentofylline. Ann N Y Acad Sci 826: 307–316.

  21. , , (2010). Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking. Biol Psychiatry 67: 81–84.

  22. , , , , , (1998). Pharmacokinetics of propentofylline and the quantitation of its metabolite hydroxypropentofylline in human volunteers. Arch Pharm Res 21: 698–702.

  23. , (2000). Identification of propentofylline metabolites in rats by gas chromatography/mass spectrometry. Arch Pharm Res 23: 374–380.

  24. , (2008). Glutamate release in the nucleus accumbens core is necessary for heroin seeking. J Neurosci 28: 3170–3177.

  25. , , , (2012). The effect of phosphodiesterase inhibitors on the extinction of cocaine-induced conditioned place preference in mice. J Psychopharmacol 26: 1375–1382.

  26. , , (2011). Cross talk between activation of microglia and astrocytes in pathological conditions in the central nervous system. Life Sci 89: 141–146.

  27. , , , , , (2012). Time course of cocaine-induced behavioral and neurochemical plasticity. Addict Biol (e-pub ahead of print).

  28. , , , , , et al (1997). A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group. Dement Geriatr Cogn Disord 8: 320–328.

  29. , , (2003). Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 23: 3531–3537.

  30. , , , , (1994). Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation. Biochem Pharmacol 47: 781–788.

  31. , , , , , (1998). Propentofylline in the treatment of vascular dementia and Alzheimer-type dementia: overview of phase I and phase II clinical trials. Alzheimer Dis Assoc Disord 12(Suppl 2): S29–S35.

  32. , , , , (2001). The glial glutamate transporter GLT-1 is localized both in the vicinity of and at distance from axon terminals in the rat cerebral cortex. Neuroscience 108: 51–59.

  33. , , , (2011). Extracellular glutamate: functional compartments operate in different concentration ranges. Front Syst Neurosci 5: 1–9.

  34. (2009). Peripheral arterial disease: pathophysiology, risk factors, diagnosis, treatment, and prevention. J Vasc Nurs 27: 26–30.

  35. , , , , , et al (2006). Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse. Neuropsychopharmacology 31: 2476–2488.

  36. , , (2012). Adenosine A2A receptors in the nucleus accumbens bi-directionally alter cocaine seeking in rats. Neuropsychopharmacology 37: 1245–1256.

  37. , (2005) The rat brain in stereotaxic coordinates 5 edn. Elsevier Academic: Amsterdam.

  38. , (2005). Astrocyte activation and reactive gliosis. Glia 50: 427–434.

  39. , , , , (2012). Methamphetamine-induced changes in the object recognition memory circuit. Neuropharmacology 62: 1119–1126.

  40. , , , , , (2012). Use of vivo-morpholinos for control of protein expression in the adult rat brain. J Neurosci Methods 203: 354–360.

  41. , , , , , et al (2011). AKAP signaling in reinstated cocaine seeking revealed by iTRAQ proteomic analysis. J Neurosci 31: 5648–5658.

  42. , , , , (1990). Propentofylline in adult-onset cognitive disorders: double-blind, placebo-controlled, clinical, psychometric and brain mapping studies. Neuropsychobiology 24: 173–184.

  43. , , , (2009). Upregulation of GLT1 attenuates cue-induced reinstatement of cocaine-seeking behavior in rats. J Neurosci 29: 9239–9243.

  44. , , , , (2012). The phosphodiesterase inhibitor isobutylmethylxanthine attenuates behavioral sensitization to cocaine. Behav Pharmacol 23: 310–314.

  45. , , (2011). Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression. J Neurosci 31: 17835–17847.

  46. , , (2004). Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res Brain Res Rev 45: 250–265.

  47. (2009). Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 32: 638–647.

  48. , (2011). Ceftriaxone prevents the induction of cocaine sensitization and produces enduring attenuation of cue- and cocaine-primed reinstatement of cocaine-seeking. Behav Brain Res 225: 252–258.

  49. , , , , , (2006). The lack of A2A adenosine receptors diminishes the reinforcing efficacy of cocaine. Neuropsychopharmacology 31: 978–987.

  50. , , (2003). Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J Neurosci 23: 2899–2910.

  51. , (2011). Propentofylline: glial modulation, neuroprotection, and alleviation of chronic pain. Handb Exp Pharmacol 200: 235–250.

  52. , , (2001). Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. J Pharmacol Exp Ther 297: 1210–1217.

  53. , , , , , et al (2008). Propentofylline-induced astrocyte modulation leads to alterations in glial glutamate promoter activation following spinal nerve transection. Neuroscience 152: 1086–1092.

  54. (2011). Methylxanthines in asthma. Handb Exp Pharmacol 200: 439–456.

  55. , , , , , et al (2012). A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation. PLoS One 7: e38312.

  56. , , , , , et al (2011). Beta-lactam antibiotic decreases acquisition of and motivation to respond for cocaine, but not sweet food, in C57Bl/6 mice. Behav Pharmacol 22: 370–373.

  57. , , , (2009). The ‘toll’ of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol Sci 30: 581–591.

  58. , , , , , (2012). Phosphodiesterase 4 inhibition impairs cocaine-induced inhibitory synaptic plasticity and conditioned place preference. Neuropsychopharmacology 37: 2377–2387.

Download references

Acknowledgements

The authors thank members of the Kalivas lab for helpful comments on a previous version of this manuscript. This work was supported by DA026254 (KJR), DA015369/DA003906 (PWK), and American Australian Association and NHMRC (RMB).

Author information

Affiliations

  1. Department of Neurosciences, Medical University of South Carolina, Charleston, SC, USA

    • Kathryn J Reissner
    • , Robyn M Brown
    • , Sade Spencer
    • , Phuong K Tran
    • , Charles A Thomas
    •  & Peter W Kalivas
  2. Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Australia

    • Robyn M Brown

Authors

  1. Search for Kathryn J Reissner in:

  2. Search for Robyn M Brown in:

  3. Search for Sade Spencer in:

  4. Search for Phuong K Tran in:

  5. Search for Charles A Thomas in:

  6. Search for Peter W Kalivas in:

Corresponding author

Correspondence to Kathryn J Reissner.

About this article

Publication history

Received

Revised

Accepted

Published

DOI

https://doi.org/10.1038/npp.2013.223

Further reading